Copyright
        ©The Author(s) 2020.
    
    
        World J Orthop. Sep 18, 2020; 11(9): 400-410
Published online Sep 18, 2020. doi: 10.5312/wjo.v11.i9.400
Published online Sep 18, 2020. doi: 10.5312/wjo.v11.i9.400
		Figure 1 Comparison of platelet counts fluctuation between low-molecular-weight heparin and fondaparinux.
		
			 LMWH: Low-molecular-weight heparin; PLT: Platelet.
		
	
		Figure 2 Percentage of patients with anti-platelet factor 4/heparin antibodies according to pharmacologic agent (P < 0.
		
			05). LMWH: Low-molecular-weight heparin.
		
	
		Figure 3 Correlation of thrombocytopenia, anti-platelet factor 4/heparin antibodies formation, heparin-induced thrombocytopenia, mutation of coagulation factors, and development of thrombosis.
		
			 HIT: Heparin-induced thrombocytopenia.
		
	
- Citation: Dailiana ZH, Stefanou N, Varitimids S, Rigopoulos N, Dimitroulias A, Karachalios T, Malizos KN, Kyriakou D, Kollia P. Factors predisposing to thrombosis after major joint arthroplasty. World J Orthop 2020; 11(9): 400-410
- URL: https://www.wjgnet.com/2218-5836/full/v11/i9/400.htm
- DOI: https://dx.doi.org/10.5312/wjo.v11.i9.400

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                         
                         
			 
			